Kitano Takahiro, Matsumura Shinji, Seki Toshihito, Hikida Takatoshi, Sakimura Kenji, Nagano Tetsuo, Mishina Masayoshi, Nakanishi Shigetada, Ito Seiji
Third Department of Internal Medicine, Kansai Medical University, Moriguchi 570-8506, Japan.
Neurochem Int. 2004 Jan;44(2):83-90. doi: 10.1016/s0197-0186(03)00124-4.
Rapid administration of large doses of ammonia leads to death of animals, which is largely prevented by pretreatment with N-methyl-D-aspartate (NMDA) receptor antagonists. The present study focuses on a subunit(s) of NMDA receptor involved in ammonia-induced death by use of NMDA receptor GluRepsilon subunit-deficient (GluRepsilon(-/-)) mice and the selective GluRepsilon2 antagonist CP-101,606. Acute ammonia intoxication was induced in mice (eight per group) by a single intraperitoneal (i.p.) injection of ammonium chloride. Appearance of neurological deteriorations depended on the doses of ammonium chloride injected. While wild-type, GluRepsilon1(-/-), GluRepsilon4(-/-), and GluRepsilon1(-/-)/epsilon4(-/-) mice all died by ammonium chloride at 12 mmol/kg during the first tonic convulsions, two of eight GluRepsilon3(-/-) mice survived. Pretreatment of wild-type mice with CP-101,606 prevented two mice from ammonia-induced death. Pretreatment of GluRepsilon3(-/-) mice with CP-101,606 prevented the death of three mice and prolonged the time of death of non-survivors. Similarly, the neuronal form of nitric oxide synthase (NOS) inhibitor 7-nitroindazole (7-NI) as well as the nonselective NOS inhibitor L-NMMA, but not the inducible NOS inhibitor 1400W, partially prevented the death of mice and prolonged the period of death. Furthermore, ammonium chloride prolonged the increase in intracellular free Ca2+ concentration ([Ca2+]i) and subsequent NO production induced by NMDA in the cerebellum. These results suggest that activation of NMDA receptor containing GluRepsilon2 and GluRepsilon3 subunits and following activation of neuronal NOS are involved in acute ammonia intoxication which leads to death of animals.
快速给予大剂量氨会导致动物死亡,而用N-甲基-D-天冬氨酸(NMDA)受体拮抗剂进行预处理可在很大程度上预防这种情况。本研究通过使用NMDA受体GluRepsilon亚基缺陷型(GluRepsilon(-/-))小鼠和选择性GluRepsilon2拮抗剂CP-101,606,聚焦于参与氨诱导死亡的NMDA受体亚基。通过单次腹腔注射氯化铵在小鼠(每组8只)中诱导急性氨中毒。神经功能恶化的出现取决于注射的氯化铵剂量。虽然野生型、GluRepsilon1(-/-)、GluRepsilon4(-/-)和GluRepsilon1(-/-)/epsilon4(-/-)小鼠在首次强直性惊厥期间,在12 mmol/kg氯化铵作用下全部死亡,但8只GluRepsilon3(-/-)小鼠中有2只存活。用CP-101,606对野生型小鼠进行预处理可使2只小鼠免于氨诱导的死亡。用CP-101,606对GluRepsilon3(-/-)小鼠进行预处理可防止3只小鼠死亡,并延长未存活小鼠的死亡时间。同样,神经元型一氧化氮合酶(NOS)抑制剂7-硝基吲唑(7-NI)以及非选择性NOS抑制剂L-NMMA,但不是诱导型NOS抑制剂1400W,可部分预防小鼠死亡并延长死亡时间。此外,氯化铵可延长NMDA诱导的小脑细胞内游离Ca2+浓度([Ca2+]i)升高及随后的NO生成。这些结果表明,含有GluRepsilon2和GluRepsilon3亚基的NMDA受体的激活以及随后神经元NOS的激活参与了导致动物死亡的急性氨中毒。